Endostatin- and interleukin-2-expressing retroviral bicistronic vector for gene therapy of metastatic renal cell carcinoma

Endostatin gene therapy enhances the efficacy of IL-2 in suppressing metastatic renal cell carcinoma in mice

(2010) Flávia Gomes de Góes Rocha et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

T regulatory cells control T-cell proliferation partly by the release of soluble CD25 in patients with B-cell malignancies

(2010) Camilla A. Lindqvist et al.   IMMUNOLOGY

The First Draft of the Endostatin Interaction Network

(2009) Clément Faye et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Natural killer cell-based immunotherapy in cancer: current insights and future prospects

(2009) T. Sutlu et al.   JOURNAL OF INTERNAL MEDICINE

Endogenous inhibitors of angiogenesis

(2009) Domenico Ribatti   LEUKEMIA RESEARCH

Involvement of ABC transporters in melanogenesis and the development of multidrug resistance of melanoma

(2009) Kevin G. Chen et al.   Pigment Cell & Melanoma Research

Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): A literature review

(2008) Kiran Gupta et al.   CANCER TREATMENT REVIEWS

Next Generation of Immunotherapy for Melanoma

(2008) John M. Kirkwood et al.   JOURNAL OF CLINICAL ONCOLOGY